Skip to main content
Methods

Recombinant Peptide Production

Recombinant production uses biological hosts to synthesize peptides, offering advantages for sequences over 50 amino acids or requiring complex disulfide formation.

By MVP Peptides Research Team
Reviewed by MVP Peptides Research Team
Published:
Last updated:

Key Points

  • 1 Recombinant production excels for peptides >50 AA or with complex disulfides
  • 2 Fusion proteins protect small peptides from degradation in host cells
  • 3 Specific proteases (TEV, SUMO protease) release target peptides
  • 4 Isotope labeling for NMR is a key advantage of recombinant production

Recombinant production complements chemical synthesis, especially for larger peptides and those requiring complex folding.

When to Use Recombinant vs. Chemical Synthesis

Factor Chemical (SPPS) Recombinant
Length <50 AA optimal >50 AA optimal
Disulfides Challenging Native folding
Unnatural AA Easy Difficult
D-amino acids Easy Impossible
Scale mg-kg mg-kg
Cost per AA High Low
Modifications Any Limited

Expression Systems

Escherichia coli **Advantages:** - Fast growth (20 min doubling) - High yields (g/L possible) - Well-characterized genetics - Low cost

  • No glycosylation
  • Limited disulfide formation (cytoplasm reducing)
  • Codon bias issues
  • Endotoxin removal required

Yeast (Pichia, Saccharomyces) **Advantages:** - Eukaryotic folding machinery - Glycosylation capable - Secretion possible - No endotoxins

  • Slower growth than E. coli
  • Hyperglycosylation (yeast-specific patterns)
  • Lower yields than E. coli

Mammalian Cells (CHO, HEK293) **Advantages:** - Human-like glycosylation - Complex protein folding - Native PTMs

  • Slow, expensive
  • Lower yields
  • Complex media requirements
  • Typically for large proteins, not peptides

The Fusion Protein Strategy

Small peptides are often toxic or unstable in bacterial cytoplasm. Solution: express as fusion proteins.

Common Fusion Partners

Partner Size Properties
GST 26 kDa High solubility
MBP 42 kDa Excellent solubility
SUMO 12 kDa Solubility, native N-terminus
Thioredoxin 12 kDa Reduces aggregation
His-tag 1 kDa Purification only

Advantages - Protect peptide from degradation - Reduce toxicity to host - Improve solubility - Enable affinity purification

Cleavage Strategies

Enzymatic Cleavage

  • Sequence: ENLYFQ↓S
  • Highly specific
  • Works at 4-30°C
  • Leaves Ser at N-terminus
  • Sequence: IEGR↓
  • Well-established
  • Can have off-target cleavage
  • Recognizes SUMO fold, not sequence
  • Leaves native N-terminus
  • Highly specific

Chemical Cleavage

  • Cleaves after Met
  • Harsh conditions
  • Must remove internal Met
  • Cleaves Asn-Gly bonds
  • Specific but limited sites

Intein Technology

Self-Cleaving Inteins - Protein splicing elements - Engineered for controlled cleavage - Generate C-terminal thioesters for NCL

IMPACT System 1. Express peptide-intein-chitin binding domain 2. Purify on chitin resin 3. Induce cleavage with thiol 4. Elute pure peptide

Isotope Labeling

Major advantage of recombinant production:

Uniform Labeling - Grow in ¹⁵N-NH₄Cl, ¹³C-glucose - All residues labeled - Essential for NMR studies

Segmental Labeling - Express labeled + unlabeled fragments - Ligate by NCL or sortase - Simplifies NMR spectra of large proteins

Case Study: Insulin Production

Historical (Before Recombinant) - Extracted from pig/cow pancreas - 8,000 lbs pancreas → 1 lb insulin - Immunogenic in some patients

Recombinant Production - Human insulin gene in E. coli or yeast - Two chains produced separately (A, B) - Refolded and oxidized together - Identical to human insulin

Test Your Knowledge

Take this quick quiz to reinforce what you've learned about recombinant peptide production.

Question 1 of 30 correct

Why are small peptides often expressed as fusion proteins in bacteria?